加载中
NASDAQTechnologySoftware - Infrastructure
最新数据
US$11.68
+US$0.27 · +2.37%
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
前收盘价
US$11.68
+US$0.27 · +2.37%
盘中时间采用ET。市场数据可能有所延迟。
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
日内区间
当前US$11.68
52周区间
当前US$11.68
盘中时间采用ET。市场数据可能有所延迟。
Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.
日内区间
当前US$11.68
52周区间
当前US$11.68
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 12.53万 USD | 162.38万 USD | 162.77万 USD | 150.55万 USD | 142.07万 USD |
| 销货成本 | 7.26万 USD | 82.61万 USD | 60.92万 USD | 50.51万 USD | 48.7万 USD |
| 毛利 | 5.27万 USD | 79.77万 USD | 101.85万 USD | 100.04万 USD | 93.37万 USD |
| 研究与开发 | 214.72万 USD | 2.6万 USD | 12.23万 USD | 32.03万 USD | 31.59万 USD |
| 销售、一般及管理费用 | 2633.06万 USD | 888.61万 USD | 905.7万 USD | 1246.96万 USD | 1170.67万 USD |
| 营业费用 | 2847.78万 USD | 1173.72万 USD | 1313.62万 USD | 2703.4万 USD | 2136.23万 USD |
| 利息支出 | — | — | — | 1065.03万 USD | — |
| 折旧和摊销 | 68.86万 USD | 69.57万 USD | 73.93万 USD | 131.31万 USD | 134.03万 USD |
| 营业利润 | −2842.52万 USD | −1093.95万 USD | −1211.77万 USD | −2603.37万 USD | −2042.86万 USD |
| 净利润 | −2.33亿 USD | −1220.13万 USD | −1398.4万 USD | −2573.76万 USD | −1965.72万 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2025年9月30日 | 1:15 | — | — |
股票拆分 | 2023年4月24日 | 1:20 | — | — |
股票拆分 | 2019年10月29日 | 1:10 | — | — |
股票拆分 | 2016年10月28日 | 1:25 | — | — |
股票拆分 | 2014年10月28日 | 1:75 | — | — |
已生效 2025年9月30日
1:15
已生效 2023年4月24日
1:20
已生效 2019年10月29日
1:10
已生效 2016年10月28日
1:25
已生效 2014年10月28日
1:75
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
